Remdesivir has ‘no impact’ on COVID-19 survivors
The antiviral drug remdesivir does not reduce deaths among COVID-19 patients, as compared with standard care, according to the results of a large, international trial. The Food and Drug Administration, in May, authorized remdesivir to be used in an emergency to treat COVID-19, after a large clinical trial suggested that the drug reduces the time […]
Remdesivir has ‘no impact’ on COVID-19 survivors Read More »


